• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The Power of One: a Highly Detailed, Log-Based, Case Example that Clearly Demonstrates the Effective Use of Ranolazine for the Control of Progressive Atrial Fibrillationn.“一”的力量：一个高度详细的、基于日志的病例示例，清晰展示了雷诺嗪在控制进行性心房颤动方面的有效应用。
J Atr Fibrillation. 2010 Oct 22;3(3):304. doi: 10.4022/jafib.304. eCollection 2010 Oct-Nov.
2
The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology.雷诺嗪与决奈达隆对人心房和心室电生理的联合作用。
J Mol Cell Cardiol. 2016 May;94:95-106. doi: 10.1016/j.yjmcc.2016.03.012. Epub 2016 Apr 4.
3
Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report.雷诺嗪治疗合并心房颤动和间歇性左束支传导阻滞的女性稳定型心绞痛——病例报告
Pol Merkur Lekarski. 2016 Dec 22;41(246):287-292.
4
Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels.雷诺嗪的抗心律失常特性：对心房颤动相关TASK-1钾通道的抑制作用。
Front Pharmacol. 2019 Nov 26;10:1367. doi: 10.3389/fphar.2019.01367. eCollection 2019.
5
Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.雷诺嗪对完整猪心脏的心房电特性有显著影响，并可缩短房颤持续时间。
J Cardiovasc Electrophysiol. 2009 Jul;20(7):796-802. doi: 10.1111/j.1540-8167.2009.01437.x. Epub 2009 Feb 27.
6
Ranolazine Therapy in Cardiac Arrhythmias.雷诺嗪治疗心律失常
Pacing Clin Electrophysiol. 2016 Sep;39(9):1006-15. doi: 10.1111/pace.12905. Epub 2016 Jul 23.
7
Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.雷诺嗪与Ⅲ类药物联合应用在心房颤动实验性全心模型中的抗心律失常作用
Cardiovasc Ther. 2013 Dec;31(6):e63-71. doi: 10.1111/1755-5922.12035.
8
Comparison of vernakalant and ranolazine in atrial fibrillation.维纳卡兰与雷诺嗪治疗心房颤动的比较。
J Cardiovasc Med (Hagerstown). 2017 Sep;18(9):663-668. doi: 10.2459/JCM.0000000000000545.
9
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.雷诺嗪治疗心房颤动：剂量范围研究RAFFAELLO（电复律后心房颤动中的雷诺嗪）的结果
Heart Rhythm. 2015 May;12(5):872-8. doi: 10.1016/j.hrthm.2015.01.021. Epub 2015 Jan 17.
10
Ranolazine for the prevention or treatment of atrial fibrillation: a systematic review.雷诺嗪预防或治疗心房颤动的系统评价。
J Cardiovasc Med (Hagerstown). 2014 Mar;15(3):254-9. doi: 10.2459/JCM.0b013e328365b554.

引用本文的文献

1
Dronedarone: Where Does it Fit in the AF Therapeutic Armamentarium?决奈达隆：在房颤治疗药物库中处于什么位置？
J Atr Fibrillation. 2013 Apr 6;5(6):752. doi: 10.4022/jafib.752. eCollection 2013 Apr-May.
2
The Use of Ranolazine in the Management of Recurrent Atrial Fibrillation After Percutaneous Radiofrequency Ablation.雷诺嗪在经皮射频消融术后复发性心房颤动管理中的应用
J Atr Fibrillation. 2012 Aug 20;5(2):562. doi: 10.4022/jafib.562. eCollection 2012 Aug-Sep.

本文引用的文献

1
Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?心房颤动的心率控制与节律控制药物治疗：2008年我们处于什么阶段？
J Atr Fibrillation. 2008 May 16;1(1):21. doi: 10.4022/jafib.21. eCollection 2008 May-Jun.
2
The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible "pill in the pocket" approach to atrial fibrillation.口服雷诺嗪用于转复新发或阵发性心房颤动：对可能采用的心房颤动“口袋药”方法的经验回顾
Indian Pacing Electrophysiol J. 2009 Sep 1;9(5):260-7.
3
Effect of dronedarone on cardiovascular events in atrial fibrillation.决奈达隆对房颤心血管事件的影响。
N Engl J Med. 2009 Feb 12;360(7):668-78. doi: 10.1056/NEJMoa0803778.
4
The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation.雷诺嗪对顽固性心房颤动患者维持窦性心律的作用。
Indian Pacing Electrophysiol J. 2008 Aug 1;8(3):175-81.
5
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial.雷诺嗪是一种具有新型电生理特性的抗心绞痛药物，对非ST段抬高型急性冠状动脉综合征患者心律失常发生率的影响：来自非ST段抬高型急性冠状动脉综合征心肌梗死溶栓36（MERLIN-TIMI 36）随机对照试验中雷诺嗪降低缺血代谢效率的结果。
Circulation. 2007 Oct 9;116(15):1647-52. doi: 10.1161/CIRCULATIONAHA.107.724880. Epub 2007 Sep 5.
6
Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine.心房选择性钠通道阻滞作为抑制心房颤动的策略：心房与心室钠通道失活的差异及雷诺嗪的作用
Circulation. 2007 Sep 25;116(13):1449-57. doi: 10.1161/CIRCULATIONAHA.107.704890. Epub 2007 Sep 4.
7
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.雷诺嗪对非ST段抬高型急性冠状动脉综合征患者心血管事件复发的影响：MERLIN-TIMI 36随机试验
JAMA. 2007 Apr 25;297(16):1775-83. doi: 10.1001/jama.297.16.1775.
8
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).美国心脏病学会/美国心脏协会/欧洲心脏病学会2006年心房颤动患者管理指南——执行摘要：美国心脏病学会/美国心脏协会实践指南工作组及欧洲心脏病学会实践指南委员会（修订2001年心房颤动患者管理指南写作委员会）报告
Eur Heart J. 2006 Aug;27(16):1979-2030. doi: 10.1093/eurheartj/ehl176.
9
Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current.雷诺嗪通过抑制晚钠电流改善心力衰竭犬左心室心肌细胞的复极化异常和收缩功能。
J Cardiovasc Electrophysiol. 2006 May;17 Suppl 1(Suppl 1):S169-S177. doi: 10.1111/j.1540-8167.2006.00401.x.
10
Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.雷诺嗪，一种具有抗心律失常特性的新型抗心绞痛药物的电生理效应。
Circulation. 2004 Aug 24;110(8):904-10. doi: 10.1161/01.CIR.0000139333.83620.5D. Epub 2004 Aug 9.

The Power of One: a Highly Detailed, Log-Based, Case Example that Clearly Demonstrates the Effective Use of Ranolazine for the Control of Progressive Atrial Fibrillationn.

作者信息

Reiffel James A

机构信息

Professor of Clinical Medicine, Columbia University.

出版信息

J Atr Fibrillation. 2010 Oct 22;3(3):304. doi: 10.4022/jafib.304. eCollection 2010 Oct-Nov.

DOI:10.4022/jafib.304
PMID:28496672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4955906/
Abstract
摘要